Please use this identifier to cite or link to this item:
|Title:||Metastatic clear cell renal cell carcinoma demonstrating intense uptake on 68Ga-DOTATATE positron emission tomography: Three case reports and a review of the literature.|
|Authors:||Nadebaum, David P;Lee, Sze Ting;Nikfarjam, Mehrdad;Scott, Andrew M|
|Affiliation:||Department of Molecular Imaging and Therapy, Austin Health, the University of Melbourne, Heidelberg, Victoria, Australia|
Olivia Newton-John Cancer Research Institute, La Trobe University, Melbourne, Victoria, Australia
Department of Surgery, Austin Health, The University of Melbourne, Heidelberg, Victoria, Australia
Olivia Newton-John Cancer Research Institute, Heidelberg, Victoria, Australia
|Citation:||World journal of nuclear medicine 2018; 17(3): 195-197|
|Abstract:||68Ga-DOTATATE positron emission tomography (PET) is a molecular imaging technology which has shown superiority over 111In-octreotide scanning for the detection and staging of neuroendocrine tumors. We report three patients with pancreatic masses that were ultimately diagnosed as clear cell renal cell carcinoma (ccRCC) metastases on histopathology. During their initial diagnostic assessment, the three patients underwent both 18F-fluorodeoxyglucose (18F-FDG) and 68Ga-DOTATATE PET. While all three patients' lesions showed variable 18F-FDG avidity, uptake on 68Ga-DOTATATE PET was comparatively intense. The small case series illustrates the need to consider ccRCC in the differential diagnosis of 68Ga-DOTATATE avid lesions.|
positron emission tomography
renal cell carcinoma
|Appears in Collections:||Journal articles|
Files in This Item:
There are no files associated with this item.
Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.